The DOI matches its Crossref record; 18 of the 18 references it cites were found in a registry or an index.
40-year trends in an index of survival for all cancers combined and survival adjusted for age and sex for each cancer in England and Wales, 1971–2011: a population-based study
Open accessAbstract
BACKGROUND: Assessment of progress in cancer control at the population level is increasingly important. Population-based survival trends provide a key insight into the overall effectiveness of the health system, alongside trends in incidence and mortality. For this purpose, we aimed to provide a unique measure of cancer survival. METHODS: In this observational study, we analysed trends in survival with population-based data for 7·2 million adults diagnosed with a first, primary, invasive malignancy in England and Wales during 1971-2011 and followed up to the end of 2012. We constructed a survival index for all cancers combined using data from the National Cancer Registry and the Welsh Cancer Intelligence and Surveillance Unit. The index is designed to be independent of changes in the age distribution of patients with cancer and of changes in the proportion of lethal cancers in each sex. We analysed trends in the cancer survival index at 1, 5, and 10 years after diagnosis for the selected periods 1971-72, 1980-81, 1990-91, 2000-01, 2005-06, and 2010-11. We also estimated trends in age-sex-adjusted survival for each cancer. We define the difference in net survival between the oldest (75-99 years) and youngest (15-44 years) patients as the age gap in survival. We evaluated the absolute change (%) in the age gap since 1971. FINDINGS: The overall index of net survival increased substantially during the 40-year period 1971-2011, both in England and in Wales. For patients diagnosed in 1971-72, the index of net survival was 50% at 1 year after diagnosis. 40 years later, the same value of 50% was predicted at 10 years after diagnosis. The average 10% survival advantage for women persisted throughout this period. Predicted 10-year net survival adjusted for age and sex for patients diagnosed between 2010 and 2011 ranged from 1·1% for pancreatic cancer to 98·2% for testicular cancer. Net survival for the oldest patients (75-99 years) was persistently lower than for the youngest (15-44 years), even after adjustment for the much higher mortality from causes other than cancer in elderly people. INTERPRETATION: These findings support substantial increases in both short-term and long-term net survival from all cancers combined in both England and Wales. The net survival index provides a convenient, single number that summarises the overall patterns of cancer survival in any one population, in each calendar period, for young and old men and women and for a wide range of cancers with very disparate survival. The persistent sex difference is partly due to a more favourable cancer distribution in women than men. The very wide differences in survival for different cancers, and the persistent age gap in survival, suggest the need for renewed efforts to improve cancer outcomes. Future monitoring of the cancer survival index will not be possible unless the current crisis of public concern about sharing of individual data for public health research can be resolved. FUNDING: Cancer Research UK.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
A new look at the statistical model identification
Akaike, H. (1974) · IEEE Transactions on Automatic Control · doi:10.1109/tac.1974.1100705 · Cited by 51,879
Royston, P., & Parmar, M. K. B. (2002) · Statistics in Medicine · doi:10.1002/sim.1203 · Cited by 1,529
Coleman, M., Forman, D., Bryant, H., Butler, J., Rachet, B., Maringe, C., Nur, U., Tracey, E., Coory, M., Hatcher, J., et al. (2011) · The Lancet · doi:10.1016/s0140-6736(10)62231-3 · Cited by 1,114
Self-citationFurther Development of Flexible Parametric Models for Survival Analysis
Lambert, P. C., & Royston, P. (2009) · The Stata Journal: Promoting communications on statistics and Stata · doi:10.1177/1536867x0900900206 · Cited by 814
On Estimation in Relative Survival
Perme, M. P., Stare, J., & Estève, J. (2012) · Biometrics · doi:10.1111/j.1541-0420.2011.01640.x · Cited by 661
Sheldon, T. A., Cullum, N., Dawson, D., Lankshear, A., Lowson, K., Watt, I., West, P., Wright, D., & Wright, J. (2004) · BMJ · doi:10.1136/bmj.329.7473.999 · Cited by 433
Studies on medical and population subjects.
Adelstein, A. M. (1976) · Cited by 408
Overdiagnosis in Mammographic Screening for Breast Cancer in Europe: A Literature Review
Puliti, D., Duffy, S. W., Miccinesi, G., De Koning, H., Lynge, E., Zappa, M., & Paci, E. (2012) · Journal of Medical Screening · doi:10.1258/jms.2012.012082 · Cited by 407
Cancer survival: global surveillance will stimulate health policy and improve equity
Coleman, M. P. (2014) · The Lancet · doi:10.1016/s0140-6736(13)62225-4 · Cited by 370
Self-citationTrends and socioeconomic inequalities in cancer survival in England and Wales up to 2001
Coleman, M. P., Rachet, B., Woods, L. M., Mitry, E., Riga, M., Cooper, N., Quinn, M. J., Brenner, H., & Estève, J. (2004) · British Journal of Cancer · doi:10.1038/sj.bjc.6601696 · Cited by 370
Self-citation
Cited by
Wang, X., Luo, G., Zhang, K., Cao, J., Huang, C., Jiang, T., Liu, B., Su, L., & Qiu, Z. (2018) · Cancer Research · doi:10.1158/0008-5472.can-17-3841 · Cited by 767
Early palliative care for adults with advanced cancer
Haun, M. W., Estel, S., Rücker, G., Friederich, H.-C., Villalobos, M., Thomas, M., & Hartmann, M. (2017) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd011129.pub2 · Cited by 757
Current status and progress of pancreatic cancer in China
Lin, Q.-J. (2015) · World Journal of Gastroenterology · doi:10.3748/wjg.v21.i26.7988 · Cited by 285
Battersby, N. J., Bouliotis, G., Emmertsen, K. J., Juul, T., Glynne-Jones, R., Branagan, G., Christensen, P., Laurberg, S., & Moran, B. J. (2018) · Gut · doi:10.1136/gutjnl-2016-312695 · Cited by 245
The Impact of Yoga on Fatigue in Cancer Survivorship: A Meta-Analysis
Armer, J. S., & Lutgendorf, S. K. (2020) · JNCI Cancer Spectrum · doi:10.1093/jncics/pkz098 · Cited by 54
Metadata
- Authors
- Quaresma, M., Coleman, M. P., & Rachet, B.
- Venue
- The Lancet
- Publisher
- Elsevier BV
- Published
- 2015-03
- Volume
- 385
- Issue
- 9974
- Pages
- 1206-1218
- ISSN
- 0099-5355 (ISSN-L)
- 0140-6736
- OpenAlex
- W2153716722
- Cited by
- 461
- References
- 18
- FWCI
- 12.21
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: 40-year trends in an index of survival for all cancers combined and survival adjusted for age and sex for each cancer in England and Wales, 1971–2011: a population-based study. https://app.cochat.ai/papers/10.1016/s0140-6736(14)61396-9
- The paper
- Quaresma, M., Coleman, M. P., & Rachet, B. (2015). 40-year trends in an index of survival for all cancers combined and survival adjusted for age and sex for each cancer in England and Wales, 1971–2011: a population-based study. The Lancet. https://doi.org/10.1016/s0140-6736(14)61396-9
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.